A total of 7,700 samples of drugs were declared not of standard quality and 670 out of total 84,874 samples selected for testing during the last three years were declared as fake or adulterated.
Government data showed that a total of 2,652 samples of drugs were declared not of standard quality and 263 out of total 84,874 samples selected for testing during the year 2020-21 were declared as fake or adulterated.
The enforcement action was taken with reference to the number of samples tested, samples declared substandard and spurious/adulterated during the last three years.
While 164 persons were arrested since the concerned authority started prosecution in the year 2020-21, over 500 such arrests were made in the last three years.
The Ministry of Health and Family Welfare in a reply in the Lok Sabha on Friday said that the manufacture, sale and distribution of drugs in the country is regulated under the provisions of the Drugs and Cosmetics Act, 1940 and the Rules, 1945.
The regulatory control over the manufacture, sale and distribution of drugs in the country is exercised through a system of licensing and inspection by the State Licensing Authorities (SLAs) appointed by the respective State Governments. The SLA reserves the right to take legal action in case of violation of the terms of the license.
The government has taken measures including strengthening of legal provisions, workshops and training programs for manufacturers and regulatory authorities, and measures such as risk-based inspections.
The Drugs and Cosmetics Act, 1940 was amended under the Drugs and Cosmetics (Amendment) Act 2008 to provide for stringent punishment for manufacture of spurious and adulterated drugs.
Some offenses Have Also Been Made Cognizable and Non-Bailable
In addition, States/UTs were requested to set up special courts for speedy disposal of offenses under the Drugs and Cosmetics Act. So far, 33 states have already set up designated special courts.